Antimicrobial and anti-inflammatory activities of the volatile oil compounds from tropaeolum majus l. (nasturtium)

African Journal of Biotechnology

Volumn 10, Issue 31, 2011, Pages 5900-5909

  Butnariu, Monica ^a   Bostan, Cristian ^a  

^a BANAT S UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

Author keywords

Anti inflammatory activity; Antimicrobial activity; Chemical compounds; Tropaeolum majus l

Indexed keywords

CEPHALOSPORIN; ESSENTIAL OIL; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFUSION; DILUTION; FLOWER; GAS CHROMATOGRAPHY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFLAMMATION; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PLANT LEAF; PLANT STEM; QUANTITATIVE ANALYSIS; TROPAEOLACEAE; TROPAEOLUM MAJUS; WATERCRESS;

ANIMALIA; TROPAEOLUM MAJUS;

EID: 79960036615     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Akinmoladun AC, Ibukun EO, Afor E, Obuotor EM, Farombi EO (2007). Phytochemical constituent and antioxidant activity of extract from the leaves of Ocimum gratissimum. Sci. Res. Essay, 2: 163-166.
2. Arai R, Sugita T, Nishikawa A (2005). Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans, Mycoses, 48: (1): 38.
3. Casadevall A, Pirofski L (2001). Adjunctive immune therapy for fungal infections, Clin. Infect. Dis., 33: 1048-1056.
4. Chatterjee A, D'Souza D, Vira T (2010). Strains of Mycobacterium tuberculosis from Western Maharashtra, India exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease and treatment failure. J. Clin. Microbiol., p. 18.
5. Dolganiuc A, Radu LD, Olinescu A (1997). The effect of products of plant and microbial origin on phagocytic function and on the release of oxygen free radicals by mouse peritoneal macrophages. Bacteriol. Virusol. Parazitol. Epidemiol., 42(1-2): 65-69.
6. Flayhart D (2007). Comparison of BACTEC Plus blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. J. Clin. Microbiol., 45: 816-821.
7. Guardabassi L, Houser GA, Frank LA (2008). Guidelines for antimicrobial use in small animals. In: Guardabassi L, Jensen LB, Hilde K. eds. Guide to Antimicrobial Use in Animals. Oxford: Blackwell Publishing, pp. 183-206.
8. Harris CS, Beaulieu LP, Fraser MH, McIntyre KL, Owen PL, Martineau LC, Cuerrier A, Johns T, Haddad PS, Bennett SA, Arnason JT (2010). Inhibition of Advanced Glycation End Product Formation by Medicinal Plant Extracts Correlates with Phenolic Metabolites and Antioxidant Activity. Planta Med., p. 17.
9. Jentschel K, Thiel D, Rehn F, Ludwig-Mueller J (2007). Arbuscular mycorrhiza enhances auxin levels and alters auxin biosynthesis in Tropaeolum majus during early stages of colonization. Physiol. Plant, 129: 320-333.
10. Luz JS, Tavares JR, Gonzales FA, Santos MC, Oliveira CC (2007). Analysis of the Saccharomyces cerevisiae exosome architecture and of the RNA binding activity of Rrp40p. Biochimie, 89: 686-691.
11. Mahesh B, Satish S (2008). Antimicrobial activity of some important medicinal plant against plant and human pathogens. World J. Agric. Sci., 4(S): 839-843.
12. Matallana L, Kleinwaechter M, Selmar D (2006). Sulfur is limiting the glucosinolate accumulation in nasturtium in vitro plants (Tropaeoluin majus L.). J. Appl. Bot., 80: 1-5.
13. Nair R, Chanda S (2006). Activity of some medicinal plants against certain pathogenic bacterial strains. Indian J. Pharmacol., 38: 142-144.
14. Nam SK, Jin HL (2010). Characterisation of phenolic phytochemicals and quality changes related to the harvest times from the leaves of Korean purple perilla (Perilla frutescens), Food Chem., 124(2): 556-562.
15. Pattnaik S, Subramanyam VR, Bapaji M, Kole CR (1997). Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios, 89: 39-46.
16. Paus R, Theoharides TC, Arck PC (2006). Neuroimmunoendocrine circuitry of the "brain-skin-connection", Trends Immunol., 27(1): 32-39.
17. Peters EMJ, Kuhlmei A, Tobin DJ, Müller-Röver S, Klapp BF, Arck PC (2005). Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin, Brain Behav. Immunol., 19: 252-262.
18. Ribeiro MF, Rocha FB, Barreto RW (2007). First record of powdery mildew caused by Oidiopsis haplophylli on Tropaeolum majus in Brazil. Plant Physiol., 56: p. 355.
19. Silva AB, Ferreres F, Malva JO, Dias ACP (2005). Phytochemical and antioxidant characterization of H. perforatum alcoholic extracts, Food Chem., 90: 157-167.
20. Swarna L, Neelakanta L, Reddy P (2009). Antimicrobial, antidiarrhoeal and analysis of phytochemical constituents of Sphaeranthus amaranthoides. Indian J. Sci. Technol. 2(3): 45-48.
21. Trott DJ, Moss SM, See AM (2007). Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin / silver sulfadiazine. Aust. Vet. J., 85: 464-466.
22. Tzakou O, Pitarokili D, Chinou IB, Harvala C (2001). Composition and antimicrobial activity of the essential oil of Salvia ringens. Planta Med., 67: 81.
23. U.S. Department of Health and Human Services. (2007). Biosafety in microbiological and biomedical laboratories, HHS Publication (CDC), 5th ed. U.S. Government Printing Office, Washington, D.C.
24. Vancanneyt M, Zamfir L, Devriese A, Lefebvre K, Engelbeen Vandemeulebroecke K, Amar M, De Vuyst L, Haesebrouck F, Swings J (2004). Enterococcus saccharominimus sp. nov., from dairy products, Int. J. Syst. Evol. Microbiol., 54: 2175-2179.
25. Vancanneyt M, Zamfir M, De Wachter M, Cleenwerck I, Hoste B, Rossi F, Dellaglio F, De Vuyst L, Swings J (2006). Reclassification of Leuconostoc argentinum as a later synonym of Leuconostoc lactis, Int. J. Syst. Evol. Microbiol., 56: 213-216.
26. Yoneyama H, Katsumata R (2006). Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci. Biotechnol. Biochem., 70(5): 1060-075.
27. Clinical and Laboratory Standards Institute (CLSI) (2007). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition M27-A3, Vol. 0 No. 0, Replaces M27-A2, 22 (15).
28. Clinical and Laboratory Standards Institute (CLSI) (2006). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-Seventh Edition. M7-A7.
29. Clinical and Laboratory Standards Institute (CLSI) (2006). Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement M100-S16, Vol. 26 No. 3, Replaces M100-S15, 25(1).
30. Directive (2000)/54/EC of the European Parliament and of the Council of 18 September 2000. On the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). Official Journal L262, 17/10/2000, p. 0021-0045.
31. FDA (2006). Bacteriological analytical manual online. Chapter 5, Disponível em: http://www.cfsan.fda.gov/~ebam/bam-5.html. Acesso em: 12 jun.
32. National Committee for Clinical Laboratory Standards (NCCLS) (2008), Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S9. National Committee for Clinical Laboratory Standards, Wayne, PA.